Our extensive hands-on expertise is backed by ten state-of-the-art facilities across the U.S. and the U.K., providing preclinical through commercial scalability and impressive scope, with a total cGMP footprint of approximately a million square feet. From increased sterile fill-finish capabilities to dry powder development, your product benefits from our combination of cutting-edge technology and high capacity.
Our global facility footprint
Select each location for a deep dive into what our facilities can offer you.
Union City
Union City is a 10,500 sq. ft. (~975 m2) research and formulation facility. We provide services in the early stages of device selection, formulation design, analytical testing, cGMP release testing, and product and process development and scale-up.
Union City at a glance:
- Expertise in all stages of product development and cutting-edge technologies
- Inhalation drug delivery (IDD) development
- Particle engineering
- Dry powder formulations
- Liquid formulations (nebulizers)
- Offers fast track to first clinic
Northridge
Northridge is a 286,000 sq. ft. (~26,570 m2) scale-up and commercial manufacturing facility. We manufacture inhalation drug delivery and transdermal drug delivery products at this location.
Northridge at a glance:
- On-site cGMP Quality Control laboratory ensures we meet client expectations while being in full regulatory compliance
- pMDI pressure and cold filling
- pMDI packaging
- Transdermal coating
- Transdermal converting
- Transdermal packaging
Bridgeton
Opening in 2024, our new, world-class facility in Bridgeton, Missouri, offers 155,000 sq. ft. (~14,400 m2) devoted to aseptic operations, including two labs, two formulation suites, and almost 11,000 sq. ft. (~1,022 m2) of fill suites. It also houses best-in-class sterility assurance isolator and automation technology.
Bridgeton at a glance:
- Designed for max efficiency, compliance, and patient safety
- Annex 1 compliance with every line
- Isolator sterility assurance technology standard
- 3 isolator high-speed filling lines
- Utilities sized to support up to 7 lines
- Rapid line changeover
- Independent filling suites
- Syringe, cartridge, and vial filling
- Formulation
- Automated PUPSIT testing
Woodbury
Woodbury is a 140,000 sq. ft. (13,006 m2) research, formulation, and development facility. Kindeva also provides regulatory consultation and warehousing with room for expansion at this location.
Woodbury at a glance:
- Offers high efficiency heating and air handling, LED lighting, networked connections
- cGMP clinical manufacturing space — clean room facilities with 7 process rooms
- Development laboratory with full range of capabilities including plume geometry, spray pattern analysis, extractables, and leachables
- Lab scale filling with any propellant (134a, 227ea, 152a, and 1234ze)
- Stability chambers with 24/7 monitoring (across full range of ICH stability conditions)
- Phase I intradermal manufacturing
Brentwood
Brentwood is a 91,760 sq. ft. (8,525 m2) aseptic operating and support manufacturing facility. It also includes warehousing and administrative offices on-site.
Brentwood at a glance:
- Fully licensed and integrated single- and dual-chamber autoinjector capability
- Formulation
- Sterile filtration
- Aseptic processing of autoinjector drug cartridges
- Engineering
- Quality control labs
Maryland Heights
Maryland Heights is a 174,850 sq. ft. (16,244 m2) inspection, device assembly, and packaging facility that manufactures finished autoinjector units. It also houses administrative offices.
Maryland Heights at a glance:
- Offers regulatory, finance, environmental health and safety, and global trade support
- Engineering and product development
- Inspection
- Labeling
- Packaging
- Warehousing
- Distribution
Lexington
Our 55,000 sq. ft. (5,109 m2) facility in Lexington, KY, houses our nasal spray operations, including development, manufacturing, and analytical support capabilities.
Lexington at a glance:
- cGMP nasal spray manufacturing
- Formulation
- Filling
- Assembly
- Labeling & packaging
- Clinical & commercial production
Clitheroe
Clitheroe is a 51,500 sq. ft. (4,785 m2) scale-up and commercial manufacturing facility. It is one of two Kindeva facilities located in the United Kingdom.
Clitheroe at a glance:
- Specializing in small and large drug-delivery device solutions and innovations
- pMDI valve, can, and sleeved can manufacture
- Supply of coated cans and componentry
- Low-GWP propellant friendly component development
Loughborough
Loughborough is a 150,000 sq. ft. (13,935 m2) research, formulation, development, scale-up manufacturing, and commercial manufacturing facility. It is one of two Kindeva locations in the United Kingdom, and it includes an extensive cleanroom facility.
Loughborough at a glance:
- Offers on-site CMC strategy and regulatory department with global product registration experience
- Independent quality organization
- MPS knowledge and capabilities
- Microbiology laboratories
- Analytical method development and validation
- pMDI pressure and cold filling
- Packaging and one-site QC laboratory
- Clinical supply
- Nasal
- Pilot-scale filling with any propellant (134a, 227ea, 152a, & 1234ze)
- BAI packaging
- Development laboratory with full range of capabilities from feasibility to commercial scale
- Stability chambers with 24/7 monitoring (across full range of ICH stability conditions)
- Transdermal drug-in adhesive systems, integrated patch overlay systems, and gel patches
- Intradermal solid and liquid formulations delivered
The power behind your product
Your product is expertly developed using only the most cutting-edge technology available.
Bringing best in class sterile fill-finish to Bridgeton
Introducing our new, world-class facility in Bridgeton, Missouri!
Opening in 2024, it includes more than 155,000 sq. ft. of dedicated aseptic operations space: two labs, two formulation suites, and approximately 11,000 sq. ft. of fill suites.
And with our world-class sterility assurance isolator and automation technology, Kindeva ensures patient safety is always a priority in the products we produce. This investment in innovation greatly expands our fill-finish capabilities while providing additional space for future expansion.
Click on the Bridgeton location on the map above for even more details!
